Helsinn pays milestone to Zealand for GLP-2 peptide agonist in chemo-induced diarrhoea
This article was originally published in Scrip
Executive Summary
Zealand Pharma has received €3 million in milestone payments under a 2008 licence deal with Swiss group Helsinn Healthcare.